Want to see TSE:CL full AI Analyst Report?
Cresco Labs (CL) Stock Price & Analysis
CL Stock Chart & Stats
- Day’s Range
- CAD 0.80 - CAD 0.85
- 52-Week Range
- CAD 0.80 - CAD 3.12
- Previous Close
- CAD 0.85
- Volume
- N/A
- Average Volume (3M)
- 77.50K
- Market Cap
- CAD 365.32M
- Enterprise Value
- CAD 1.17B
- Total Cash (Recent Filing)
- CAD 32.87M
- Total Debt (Recent Filing)
- CAD 592.02M
- Price to Earnings (P/E)
- ―
- Beta
- 2.21
- Next Earnings
- Nov 06, 2026 (Est.)
- EPS Estimate
- -0.02
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Operating Improvement And Gross Margin
Positive EBIT and EBITDA show that Cresco’s core operations have improved, while a gross margin near 48% provides room to support overhead, reinvestment, and brand development. If maintained, this operating base could help the company move toward durable profitability.
Positive Operating Cash Flow
Positive operating cash flow indicates that the business is generating cash from its activities despite reported net losses. This provides an internal funding base for ongoing operations and can improve financial resilience if cash conversion becomes more consistent over time.
Integrated Multi-Channel Business Model
Operating across production, wholesale, and owned retail gives Cresco multiple routes to reach regulated-market consumers and capture value across the cannabis chain. Its branded products and dispensaries can support market access, customer reach, and channel diversification over the medium term.
Bears Say
Persistent Net Losses
The company remains materially unprofitable at the bottom line, showing that operating gains have not yet translated into sustainable earnings for shareholders. Negative ROE also indicates that the existing capital base is not currently producing adequate returns, limiting financial quality.
Elevated Leverage
High debt relative to equity reduces balance-sheet flexibility and leaves less room to absorb operating setbacks or fund expansion internally. Declining equity compounds the concern, because the company must improve earnings power while carrying a comparatively heavy capital structure.
Unstable Revenue And Cash Conversion
A history of uneven revenue, including declines across several years, makes it harder to establish a dependable growth trajectory. Volatile free cash flow adds uncertainty around self-funding capacity, limiting confidence that recent operating improvement will persist.
Cresco Labs News
CL FAQ
What was Cresco Labs’s price range in the past 12 months?
What is Cresco Labs’s market cap?
When is Cresco Labs’s upcoming earnings report date?
How were Cresco Labs’s earnings last quarter?
Is Cresco Labs overvalued?
Does Cresco Labs pay dividends?
What is Cresco Labs’s EPS estimate?
How many shares outstanding does Cresco Labs have?
What happened to Cresco Labs’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Cresco Labs?
What is the TipRanks Smart Score and how is it calculated?
Cresco Labs Stock Smart Score
Company Description
Cresco Labs
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy’s brand, as well as Loud*r brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Charles Bachtell
- Employees
- 2,900
- Website
- www.crescolabs.com
- Address
- 600 W. Fulton Street, Chicago, IL, 60661, US
Cresco Labs (CL) Earnings & Revenues
CL Company Deck
CL Earnings Call
Earnings Call SentimentPositive
The call presents a cautiously optimistic outlook: management delivered solid Q1 margins and EBITDA from a streamlined cost structure, achieved meaningful operational and licensing wins (PA store expansion, Ohio openings, Kentucky harvest, Texas license) and provided constructive Q2 growth guidance (~+10% revenue). Offsets include near-term revenue headwinds from the planned California exit and Michigan excise tax, ongoing pricing compression, seasonal cash flow timing, and unresolved regulatory details around rescheduling (including the scope and timing of 280E relief). On balance, operational momentum, accretive M&A activity, and licensing progress outweigh the short-term market and regulatory challenges.
View all TSE:CL earnings summariesCL Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 3 | 5 | 14 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 0 | 0 | 12 |
